Alexander Blair is a Partner in Deloittes Life Sciences practice, where he specializes in corporate strategy, growth, and innovation for biopharma clients. He holds an MBA from The Wharton School and a Master of Engineering from Cornell University, focusing on transforming commercialization and drug launch strategies.
Prior to his current role, Alexander served as a Program Manager for the Clinton Health Access Initiative, addressing global health challenges.
He has published insights on how a product launch can be a microcosm of a company’s overall performance and effectiveness.